Abstract
Bioluminescence imaging is a highly sensitive technique commonly used for various in vivo applications. Recent efforts to expand the utility of this modality have led to the development of a suite of activity-based sensing (ABS) probes for bioluminescence imaging by ‘caging’ of luciferin and its structural analogs. The ability to selectively detect a given biomarker has presented researchers with many exciting opportunities to study both health and disease states in animal models. Here, we highlight recent (2021–2023) bioluminescence-based ABS probes with an emphasis on probe design and in vivo validation experiments.
Original language | English (US) |
---|---|
Article number | 102310 |
Journal | Current Opinion in Chemical Biology |
Volume | 74 |
DOIs | |
State | Published - Jun 2023 |
ASJC Scopus subject areas
- Analytical Chemistry
- Biochemistry